Form 4: Select Medical Holdings Corp Director Khanuja Acquires Shares
SEC Form 4
Director Parvinderjit S. Khanuja acquired shares of Select Medical Holdings Corp, including restricted stock grants in lieu of a quarterly retainer.
Summary
- On April 30, 2024, Parvinderjit S. Khanuja, a director of Select Medical Holdings Corp, acquired 634 shares of common stock at $28.37 per share.
- Khanuja also received a grant of 10,000 shares of restricted stock, which will vest on April 30, 2025.
- The restricted stock grant was issued in lieu of a $18,000 quarterly retainer.
- Following these transactions, Khanuja beneficially owns 43,093 shares of Select Medical Holdings Corp.
- The transactions were reported on May 1, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Positives
- The director's acquisition of shares could be seen as a positive signal to the market.
Future Outlook
The restricted stock will vest on April 30, 2025, subject to certain exceptions.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The director's stock acquisition may have a minor positive impact on shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 04/30/2024 | Date of stock acquisition and restricted stock grant |
| 04/30/2025 | Vesting date for the restricted stock grant |
| 05/01/2024 | Date of report filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.